Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis - Hassan, Mona; Merza, Nooraldin; Nawras, Yusuf; Alfatlawi, Halah; al obaidi, hasan; Saab, Omar; Al Zubaidi, Khalid; Al-sabbagh, Daniah; mansur, Sarmed; Algodi, Marwah; Al Najafi, Omer; Matbachi, Rand; et al. (Translation: The University of Toledo Journal of Medical Sciences, 2025)